NeuroMetrix, Inc. Appoints David Van Avermaete to Board of Directors
Published: Oct 01, 2013
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today announced that it has appointed David Van Avermaete to its Board of Directors.
Help employers find you! Check out all the jobs and post your resume.